Investors are turning to dividend giants like AbbVie, AT&T, and Target for reliable income

In times of market volatility, investors turn to dependable dividend giants like AbbVie. With a market value of $328 billion, AbbVie offers a 3.5% dividend yield, a low payout ratio, and a history of 53 consecutive years of dividend growth. Its top drug, Humira, faces patent expiration, but new drugs like Skyrizi and Rinvoq are driving sales growth.

AT&T, a major telecommunications company worth $208 billion, offers a 3.85% dividend yield and improved payout ratio of 49.7%. With strong free cash flow and rising earnings, AT&T aims to generate over $16 billion in free cash flow by 2025 to support dividends. Analysts rate the stock a “Moderate Buy” with potential upside of 17.5%.

Target, valued at $45 billion, is a Dividend Aristocrat with over 54 years of consecutive dividend growth. Offering a 4.4% dividend yield, Target’s stable financials and adaptable business model make it a reliable dividend payer. With a sustainable payout ratio and solid first-quarter earnings growth, Target stock is rated a “Moderate Buy” with upside potential of 10.9%.

Read more at Yahoo Finance: 3 Giant Dividend Stocks to Buy to Shield Your Portfolio Now